NEWS
22 October 2025

VirClia® reaches a new global milestone with over 25 million tests performed worldwide, reinforcing Vircell’s commitment to reliability, precision, and innovation in laboratory automation.

A milestone built on trust and innovation

Since its launch, the VirClia® system has become a reference in automated chemiluminescent immunoassays, helping laboratories simplify their daily workflows and improve result consistency. The figure of 25 million tests demonstrates the global adoption of the platform and its impact on laboratory efficiency and patient care.

A global presence

VirClia® is used in laboratories around the world, supporting healthcare professionals in the early detection and monitoring of infectious diseases. Its versatility and automation make it a valuable tool for laboratories of different sizes and capacities.

SHARE:

LATEST NEWS

DO YOU HAVE ANY QUESTIONS?

Contact us